Ginkgo Bioworks Holdings, Inc. (DNA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 49,604 | 48,318 | 89,046 | 56,206 |
| Restructuring charges | - | - | - | 17,066 |
| Cost of biosecurity revenue | - | 12,047 | - | - |
| Restructuring charges | 3,674 | 5,273 | - | - |
| Research and development | 53,370 | 70,923 | - | 134,221 |
| Goodwill, impairment loss | - | - | - | 47,858 |
| General and administrative | 43,279 | 49,043 | - | 66,285 |
| Cost of biosecurity revenue-Product And Service Other | 5,380 | - | - | - |
| Cost of biosecurity revenue-Biosecurity Segment | 9,442 | - | - | - |
| Total operating expenses | 115,145 | 137,286 | 144,250 | 279,151 |
| Loss from operations | -65,541 | -88,968 | -55,204 | -222,945 |
| Interest income, net | - | - | -9,251 | -10,313 |
| Deconsolidation, gain (loss), amount | - | - | -7,013 | - |
| Other income (expense), net | -896 | -4,289 | 1,572 | -766 |
| Interest income, net | 6,083 | 6,081 | - | - |
| Loss on investments | -229 | -3,693 | -6,912 | -6,826 |
| Change in fair value of warrant liabilities | - | - | -1,528 | -3,233 |
| Total other income | 4,958 | -1,901 | -1,574 | 5,954 |
| Loss before income taxes | -60,583 | -90,869 | -56,778 | -216,991 |
| Income tax (benefit) expense | -283 | 88 | -375 | 190 |
| Net loss | -60,300 | -90,957 | - | - |
| Foreign currency translation adjustment | 2,586 | - | - | -172 |
| Debt securities, available-for-sale, unrealized gain (loss) | -83 | - | - | - |
| Total other comprehensive (loss) income | 2,503 | - | - | - |
| Net loss | - | - | -56,403 | -217,181 |
| Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary | - | - | -1,492 | - |
| Foreign currency translation adjustment | - | - | 494 | - |
| Total other comprehensive income (loss) | - | - | 1,986 | -172 |
| Comprehensive loss | -57,797 | -90,957 | -54,417 | -217,353 |
| Basic (in shares) | 54,858,982 | 54,241,619 | 52,240,000 | 2,054,801,000 |
| Diluted (in shares) | 54,858,982 | 54,241,619 | 52,246,000 | 2,055,024,000 |
| Net loss per share, basic (in dollars per share) | -1.1 | -1.68 | -1.08 | -0.11 |
| Net loss per share, diluted (in dollars per share) | -1.1 | -1.68 | -1.08 | -0.11 |